BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25860128)

  • 1. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
    Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Catulin knockdown induces senescence in cancer cells.
    Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
    Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.
    Nacerddine K; Lehembre F; Bhaumik M; Artus J; Cohen-Tannoudji M; Babinet C; Pandolfi PP; Dejean A
    Dev Cell; 2005 Dec; 9(6):769-79. PubMed ID: 16326389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Sumoylation in Senescence.
    Scurr LL; Haferkamp S; Rizos H
    Adv Exp Med Biol; 2017; 963():215-226. PubMed ID: 28197915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles for SUMO modification during senescence.
    Andreou AM; Tavernarakis N
    Adv Exp Med Biol; 2010; 694():160-71. PubMed ID: 20886763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUMO-specific protease SENP5 is required for cell division.
    Di Bacco A; Ouyang J; Lee HY; Catic A; Ploegh H; Gill G
    Mol Cell Biol; 2006 Jun; 26(12):4489-98. PubMed ID: 16738315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO targets the APC/C to regulate transition from metaphase to anaphase.
    Eifler K; Cuijpers SAG; Willemstein E; Raaijmakers JA; El Atmioui D; Ovaa H; Medema RH; Vertegaal ACO
    Nat Commun; 2018 Mar; 9(1):1119. PubMed ID: 29549242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation.
    Neyret-Kahn H; Benhamed M; Ye T; Le Gras S; Cossec JC; Lapaquette P; Bischof O; Ouspenskaia M; Dasso M; Seeler J; Davidson I; Dejean A
    Genome Res; 2013 Oct; 23(10):1563-79. PubMed ID: 23893515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia regulates sumoylation pathways in intervertebral disc cells: implications for hypoxic adaptations.
    Wang F; Cai F; Shi R; Wei JN; Wu XT
    Osteoarthritis Cartilage; 2016 Jun; 24(6):1113-24. PubMed ID: 26826302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
    Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
    Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
    He X; Riceberg J; Soucy T; Koenig E; Minissale J; Gallery M; Bernard H; Yang X; Liao H; Rabino C; Shah P; Xega K; Yan ZH; Sintchak M; Bradley J; Xu H; Duffey M; England D; Mizutani H; Hu Z; Guo J; Chau R; Dick LR; Brownell JE; Newcomb J; Langston S; Lightcap ES; Bence N; Pulukuri SM
    Nat Chem Biol; 2017 Nov; 13(11):1164-1171. PubMed ID: 28892090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.